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Summary
 
The capacity of activated T cells to alter their cytokine expression profiles after migration into
an effector site has not previously been defined. We addressed this issue by paired daughter
analysis of a type 1–polarized CD8
 
1
 
 effector T cell population freshly isolated from lung paren-
chyma of influenza virus–infected mice. Single T cells were activated to divide in vitro; indi-
vidual daughter cells were then micromanipulated into secondary cultures with and without
added IL-4 to assess their potential to express type 2 cytokine genes. The resultant subclones
were analyzed for type 1 and 2 cytokine mRNAs at day 6–7. When the most activated
(CD44
 
high
 
CD11a
 
high
 
) CD8
 
1
 
 subpopulation from infected lung was compared with naive or
resting (CD44
 
low
 
CD11a
 
low
 
) CD8
 
1
 
 cells from infected lung and from normal lymph nodes
(LNs), both clonogenicity and plasticity of the cytokine response were highest in the LN pop-
ulation and lowest in the activated lung population, correlating inversely with effector func-
tion. Multipotential cells were nevertheless detected among clonogenic CD44
 
high
 
CD11a
 
high
 
lung cells at 30–50% of the frequency in normal LNs. The data indicate that activated CD8
 
1
 
 T
cells can retain the ability to proliferate and express new cytokine genes in response to local
stimuli after recruitment to an effector site.
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N
 
aive CD4
 
1
 
 and CD8
 
1
 
 T cells have the potential to
express many different cytokine genes in various
combinations, depending on signals received during and af-
ter primary activation (1–4). This has been demonstrated
most directly in experiments where sublines or subclones of
a single parental cell displayed different cytokine profiles
when expanded in different culture conditions (5–7). Al-
though these studies do not exclude genetic and develop-
mental effects on the propensity to express some cytokine
genes (8–10), they suggest that most, if not all, naive CD4
 
1
 
and CD8
 
1
 
 T cells can respond flexibly to stimulation con-
ditions in the periphery. Many factors can influence the cy-
tokine profile of a responding T cell population, but the
most striking effects are exerted by the cytokines IL-12 and
IFN-
 
g
 
, which promote the expression of IFN-
 
g
 
 and other
type 1 cytokines, and IL-4, which promotes the expression
of IL-4 and other type 2 cytokines (11–14).
Several groups have shown that CD4
 
1
 
 T cell popula-
tions activated in vitro progressively lose the ability to
change their cytokine profile when transferred from type 1
to type 2 polarizing conditions or vice versa (15–19). These
data and other work showing that many long-term CD4
 
1
 
and CD8
 
1
 
 T cell clones also display stable cytokine profiles
(3, 6, 16, 20) suggest that activated T cells ultimately be-
come irreversibly committed to the expression of a particu-
lar cytokine profile in vitro. A molecular basis for this loss
of multipotentiality has been suggested by observations that
type 2–polarized cells lose IL-12R
 
b
 
2 expression and type
1–polarized cells, while retaining surface IL-4R, lose IL-4
responsiveness (21–24). Stable demethylation of cytokine
gene promoters, changes in chromatin structure, and in-
duction of type-specific transcription factor expression
probably also contribute to the maintenance of cytokine
gene expression patterns under different stimulation condi-
tions (25–32).
Less is known about the stability of T cell cytokine pro-
files in vivo, but the available data indicate that established
T cell cytokine responses are more difficult to deviate than
primary responses (33–37). Memory CD4
 
1
 
 and CD8
 
1
 
 T
cell populations expressed their original cytokine profiles
when restimulated after many weeks in vivo in the absence
of antigen (18, 38, 39), suggesting that these gene expres- 
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sion patterns are “imprinted” during priming. Mocci and
Coffman found that CD4
 
1
 
 T cells of memory (CD62L
 
low
 
)
phenotype isolated from 
 
Leishmania major
 
–infected mice re-
tained their type 1 profile when exposed to IL-4 in vitro,
although undifferentiated 
 
L. major
 
–reactive cells persisted in
the naive CD62L
 
high
 
 fraction (36). Reports that allergic de-
sensitization and other protocols shift the IL-4/IFN-
 
g
 
 ratio
produced by antigen-specific T cells show that redirection
of cytokine responses can occur in vivo (35, 40–42). How-
ever, it is not known whether this occurs by replacing or
reprogramming existing effector cells.
This uncertainty highlights a major limitation of popula-
tion studies, both in vivo and in vitro. Since the fate of
every cell cannot be monitored, it is usually unclear
whether any change in cytokine profile is due to repro-
gramming of the cells or to selective outgrowth by a minor
subpopulation. Similarly, the apparent stability of a popula-
tion phenotype might reflect true commitment or other
mechanisms, such as selective apoptosis (43), or a dominant
cross-regulatory effect of cytokines from some of the cells
on the response of other multipotential cells in the popula-
tion (44). These limitations can be overcome by single-cell
protocols in which the survival and cytokine profile of each
cell or its progeny are assessed. Paired daughter analysis in
particular can be used to identify and quantify multipoten-
tial cells by measuring the ability of daughters of a single
cell to respond differently to different stimuli (7, 45).
Here we report the use of paired daughter analysis to de-
termine whether multipotential cells persist in a CD8
 
1
 
 ef-
fector T cell population ex vivo. The analyzed population
comprised activated CD8
 
1
 
 cells freshly isolated from the
lung parenchyma of influenza virus–infected mice at the
peak of the local response. This population had previously
been shown to synthesize IFN-
 
g
 
 with little or no detect-
able IL-4 both ex vivo and after in vitro restimulation with
virus-infected cells (46–49). As shown here, a significant
proportion of these cells retained the potential to respond
to IL-4 by expressing IL-4 and/or IL-10. These findings
suggest that activated T cells can leave the priming LN be-
fore undergoing irreversible commitment and retain the
capacity to modulate their phenotype in response to local
conditions at the effector site.
 
Materials and Methods
 
Mice and Influenza Infection.
 
Female 6–10-wk-old BALB/c
mice purchased from the Animal Resources Centre (Perth,
Western Australia) were used in all experiments. Mice were anes-
thetized with ether or Penthrane (Abbott Australasia Pty. Ltd.)
and infected intranasally with 50 
 
m
 
l of PBS containing 5 
 
3
 
 10
 
5
 
PFU of the reassortant influenza A virus Mem71 (H3/N1). The
viral stock, prepared in embryonated chicken eggs, was provided
by Dr. Lorena Brown (University of Melbourne, Victoria, Aus-
tralia).
 
T Cell Preparation.
 
Normal LN cell suspensions were pre-
pared from pooled paraaortic, axillary, and inguinal LNs of unin-
fected mice by forcing through stainless steel mesh, and centrifu-
gation over Ficoll-Paque (Amersham Pharmacia Biotech). To
prepare lung cell suspensions, mice were killed 7 d after influenza
infection, perfused in situ with balanced salt solution to remove
blood cells, and the lungs were minced and digested with collage-
nase and DNase as described previously (49). Digested lung was
passed through stainless steel mesh, and parenchymal cells were
isolated by centrifugation over a gradient of Percoll (Amersham
Pharmacia Biotech). Cells were stained for flow cytometry with
PE-conjugated anti-CD8 mAb (53.6; Becton Dickinson) and bi-
otinylated anti-CD44 mAb (IM7.8; PharMingen), followed by
streptavidin-Tricolor (Caltag) and FITC-conjugated anti-CD11a
mAb (Sigma Chemical Co.), then resuspended in balanced salt
solution with 1 
 
m
 
g/ml propidium iodide. CD8
 
1
 
CD44
 
low
 
CD11a
 
low
 
 and CD8
 
1
 
CD44
 
high
 
CD11a
 
high
 
 cells were isolated using
a FACS Vantage™ (Becton Dickinson) with Lysys II software,
setting a small forward scatter/side scatter gate to collect cells
from normal LNs and a large gate to include both small lympho-
cytes and larger activated cells from lung. Dead and damaged cells
were excluded on the basis of propidium iodide uptake and low
forward scatter. By reanalysis, purity of the initial bulk-sorted
cells for any of the tested staining parameters was generally
 
.
 
96%. Cells were then resorted using the same parameters and
deposited using an automated cell deposition unit directly into
microwells for RNA extraction or cloning.
On average in this study, CD8
 
1
 
 cells with the naive pheno-
type CD44
 
low
 
CD11a
 
low
 
 from LNs of untreated mice (“normal
LN
 
low
 
 cells”) comprised 40.5% (
 
n 
 
= 2) of the CD8
 
1
 
 LN cell pool.
CD8
 
1
 
 cells comprised 18.1% 
 
6
 
 4.5 of the 15.2 
 
6
 
 7.6 
 
3
 
 10
 
6
 
 lung
leukocytes recovered per mouse at day 7 after infection. Of the
CD8
 
1
 
 fraction, 32.8% 
 
6
 
 4.4 were defined as CD44
 
low
 
CD11a
 
low
 
(“influenza lung
 
low
 
”) and 37.0% 
 
6
 
 5.3 were defined as CD44
 
high
 
CD11a
 
high
 
 (“influenza lung
 
high
 
”), as illustrated previously (49).
 
T Cell Cloning and Subcloning.
 
All cultures were performed in
15 
 
m
 
l volumes of supplemented DME containing 5 
 
3
 
 10
 
2
 
5
 
 M
2-ME, 12.5% FCS, and 600 IU/ml recombinant human IL-2
(Cetus Corp.) in mAb-coated Terasaki microwells (Greiner
Labortechnik) (50). For normal LN cells, microwells were coated
with purified mAb to CD3
 
e
 
 (145-2C11; 10 
 
m
 
g/ml), CD8 (53.6;
3 
 
m
 
g/ml), and CD11a (I21/7.7; 5 
 
m
 
g/ml). Antibody coating
concentrations were altered to 3 
 
m
 
g/ml anti-CD3, 3 
 
m
 
g/ml anti-
CD8, and 5 
 
m
 
g/ml anti-CD11a mAb for optimal cloning of in-
fluenza lung
 
low
 
 cells, and to 1 
 
m
 
g/ml anti-CD3, 5 
 
m
 
g/ml anti-
CD8, and 5 
 
m
 
g/ml anti-CD11a mAb for influenza lung
 
high
 
 cells.
For experiments where clones were generated under different
conditions in parallel, all cultures were initiated with mAb and
IL-2, then after 2 d, 5 
 
m
 
l medium was removed and replaced
with 5 
 
m
 
l medium containing various combinations of IL-2 (final
concentration 600 IU/ml), IL-4 (100 U/ml), and anti–IFN-
 
g
 
mAb (supernatant of the hybridoma R4-6A2 at a concentration
that reduced the activity of purified rIFN-
 
g
 
 by at least 30-fold in
assays with WEHI-279 cells). For paired daughter analysis, cul-
tures were initiated with mAb and IL-2, then checked micro-
scopically for viable cells at day 2. Where a parent cell had di-
vided one or two times, individual daughter or granddaughter
cells were transferred by micromanipulation into new Terasaki
wells coated with the same mAb as above: at least one cell was
cultured with IL-2 and one with IL-2 plus 100 U/ml IL-4. After
a total of 6 or 7 d, cultures were checked microscopically for
clones or subclones, cell numbers were counted, and their RNA
was extracted. Clone sizes of 
 
$
 
200 cells were recorded as 200.
 
Reverse Transcription PCR.
 
Cells were lysed for reverse tran-
scription (RT)
 
1
 
 using NP-40 by the method of Smith et al. (51),
 
1
 
Abbreviation used in this paper:
 
 RT, reverse transcription. 
1083
 
Doyle et al.
 
modified by combining the buffered saline solution and the lysis
mix, and by including oligo-dT
 
15
 
 (18 
 
m
 
g/ml final concentration;
Boehringer Mannheim) as a primer instead of random hexamers.
Cells were sorted directly into 11 
 
m
 
l of combined buffered lysing
solution, or clones and subclones were lysed in microwells by re-
placement of culture medium with 11 
 
m
 
l of buffered lysing solu-
tion. Cell lysates were heated to 65
 
8
 
C then quick-chilled, trans-
ferred to microfuge tubes containing 14 
 
m
 
l RT mix comprising
90 mM KCl, 18 mM Tris-HCl, pH 8.0, 12 mM MgCl
 
2
 
, 1.4 mM
dithiothreitol, 700 
 
m
 
M of each dNTP, 10 U RNAsin, and 2 U
AMV reverse transcriptase (Promega Corp.), and incubated at
42
 
8
 
C for 90 min. First strand cDNA products were diluted 1:2.4
in H
 
2
 
O, and 10 
 
m
 
l was added to 15 
 
m
 
l PCR mix consisting of
2.5 
 
m
 
l of 10
 
3
 
 PCR buffer (500 mM KCl, 100 mM Tris-HCl,
pH 8.0, 20 mM MgCl
 
2
 
), 0.25 
 
m
 
l of mixed dNTPs (20 mM; Am-
ersham Pharmacia Biotech), 1 U Ampli-Taq polymerase (Perkin-
Elmer), 1 
 
m
 
l of each external oligonucleotide primer (10 
 
m
 
M),
and H2O. PCR samples were amplified for 40 cycles in the first
round, then products were diluted 1:33 in H2O, and 2 ml was
added to 23 ml PCR mix, as above, for the second round of 30
cycles of PCR with internal intron-spanning primer pairs. PCR
cycles were one cycle of 5 min at 948C, 60 s at 608C, and 90 s at
708C, with subsequent cycles of 45 s at 948C, 60 s at 608C, and
90 s at 708C. Primer pairs were as described previously (7). First
round amplifications were performed with the following combi-
nations of primers: IL-4, IFN-g, and CD3e; IL-5 and IL-6; IL-2
and IL-10. In the second round, the respective first round prod-
ucts were amplified as follows: IL-4 and IFN-g together, CD3e
separately; IL-5 and IL-6 together; IL-2 and IL-10 separately.
PCR products were separated by gel electrophoresis, visualized
with ethidium bromide, and confirmed by Southern hybridiza-
tion (50). All PCR runs included a titration of cloned CD3e and
cytokine cDNA to monitor cDNA sensitivity (at least 10216 g,
usually 10217 g, with no consistent differences between cyto-
kines) and 10 negative control samples. No PCR products were
detected in the negative control samples.
Clones were scored as positive for expression of a cytokine if
the corresponding PCR product was identified unambiguously
by electrophoretic migration at the appropriate size and Southern
hybridization with a specific probe. PCR amplifications from
clonal cDNA samples were repeated in several experiments.
Overall, reproducibility of positive and negative results was 96%
for IFN-g (n = 306), 94% for IL-4 (n = 306), 100% for IL-2 (n =
23), and 98% for IL-10 (n = 129). Both losses and gains were ob-
served on repetition, suggesting that variations were because the
relevant cDNA was limiting in those samples.
Results
Isolation and Cloning of Activated CD81 T Cells from Lung
Parenchyma of Influenza Virus–infected Mice. Previous ex-
periments established that intranasal infection of BALB/c
mice with the Mem71 reassortant influenza virus caused
accumulation in the lung parenchyma of a population of
activated CD81 T cells that expressed mRNA for IFN-g
and other cytokines ex vivo, secreted high levels of IFN-g
in response to virus-infected cells in vitro, and contained
virus-specific CTLs (46, 48, 49). At the peak of the cellular
response at day 7, both cytokine production and lytic activ-
ity were markedly higher in CD81 T cells from the lung
than from the draining mediastinal LNs. Separation on the
basis of high CD44 and CD11a expression achieved greater
enrichment of this CD81 effector activity from both lung
and LNs than any other combination of activation markers
tested (49). Therefore, these markers were used in the
following experiments to distinguish the least activated
(CD44lowCD11alow) and the most activated (CD44high
CD11ahigh) lung parenchymal CD81 T cells from 7-d influ-
enza virus–infected mice (abbreviated as influenza lunglow
and influenza lunghigh cells, respectively). Low expression of
CD44 and CD11a was also used to define a control CD81
population of naive phenotype from normal LNs (normal
LNlow cells).
The basal patterns of expression of several cytokine
mRNAs in multiple samples of 500 normal LNlow, influ-
enza lunglow, or influenza lunghigh cells were analyzed by
RT-PCR immediately after FACS® purification (Fig. 1),
Figure 1. Cytokine mRNA expression by freshly isolated CD81 cells
from normal LNs and influenza virus–infected lung. RNA was prepared
from multiple samples of 500 cells of (A) normal LNlow cells, (B) influenza
lunglow cells, and (C) influenza lunghigh cells immediately after purification
by FACS® and analyzed for CD3e and cytokine mRNA by RT-PCR.
Data are shown for all samples that yielded a CD3e PCR product (89 of
90 samples) and pooled from at least two experiments (six samples per ex-
periment). The number of samples tested is shown beside each bar; nd,
not detected.1084 Flexible Cytokine Profiles of Activated CD81 T Cells from an Effector Site
using methods previously shown to detect cytokine tran-
scripts in single activated T cells (52, 53). No cytokine ex-
pression was detected in any of the normal LN samples,
whereas almost all samples of influenza lunglow and influ-
enza lunghigh cells expressed IFN-g mRNA. The influenza
lunghigh population also frequently expressed IL-10 and oc-
casionally one or more of the cytokines IL-2, IL-4, and IL-
6. These data show the expected hierarchy of effector ac-
tivity in the three populations and support earlier evidence
that IFN-g is a major product of CD81 T cells in the re-
sponse to influenza virus infection (46, 47, 49).
To assess the potential of activated T cells to alter their
cytokine profiles in response to different signals, a culture
system was required in which isolated single cells would di-
vide and could then be subcloned under different condi-
tions before analysis of their cytokine profiles. Ideally cul-
tures would lack accessory cells to enable identification of
individual daughter cells for subcloning and to ensure that
cytokine mRNAs measured by RT-PCR at the end of
culture were derived from the progeny of those daughter
cells. We have previously shown that stimulation with
coimmobilized anti-CD3 (adsorbed to culture wells at 10
mg/ml), anti-CD8, and anti-CD11a mAb and IL-2 acti-
vated most naive CD81 LN cells to form clones (7, 50, 54).
When influenza lunghigh cells were cultured under these
conditions, cloning frequencies and sizes were low. A series
of optimization experiments showed that reduction of the
plate-coating concentration of anti-CD3 mAb to 1 mg/ml
increased cloning efficiencies of these cells to a mean of
z25% (data not shown). No further improvement was ob-
tained by varying the other mAb concentrations. Maximal
cloning efficiencies of z75% were obtained for influenza
lunglow cells using 3 mg/ml anti-CD3 mAb, comparable to
those achieved for normal LN CD81 T cells using 10 mg/
ml (z80%). Average clone sizes peaked at 6–7 d of culture,
after which many clones died.
The ability of exogenous IL-4 to influence cytokine pro-
file development in influenza lunghigh cells was tested by
culturing individual cells with immobilized mAb and IL-2.
After 2 d, cultures were supplemented with medium, IL-4,
or IL-4 and anti–IFN-g mAb, to mimic the protocol used
in the paired daughter analyses shown below. All clones
were counted and harvested on day 6 for RT-PCR analysis
of their cytokine profiles (Fig. 2). Average cloning efficien-
cies, clone sizes, and frequencies of IFN-g, IL-2, and IL-10
mRNA expression were comparable among the three sets
of cultures (P . 0.05). However, addition of IL-4 at day 2
markedly increased the frequency of IL-4 expression (P ,
0.01). No further increase was observed when anti–IFN-g
mAb was also added. This and other preliminary cloning
experiments suggested that a significant proportion of in-
fluenza lunghigh and influenza lunglow cells could respond to
IL-4 by expressing this cytokine, providing provisional evi-
dence for the presence of multipotential cells in both popu-
lations. RT-PCR analyses of IL-5 and IL-6 expression by
the clones in Fig. 2 and many other clones derived from in-
fluenza lunghigh or influenza lunglow cells in the presence or
absence of exogenous IL-4 rarely detected either of these
cytokine mRNAs, and are therefore not presented.
Paired Daughter Analysis of Lung CD81 T Cells. As shown
above in Fig. 2, IL-4 mRNA–expressing clones could be
generated from influenza lunghigh cells in the presence of
exogenous IL-4. However, this experimental protocol did
not distinguish whether these clones developed de novo
from multipotential cells or whether they were expanded
from committed cells that had been primed to produce this
cytokine in vivo. To address this question directly, paired
daughter analyses were performed in which CD81 cells
Figure 2. The effect of IL-4 on cytokine
mRNA expression by clones of lung CD81
CD44highCD11ahigh cells. Individual
FACS®-purified CD81 CD44highCD11ahigh
cells from influenza virus–infected lung
were  deposited into wells coated with mAb
to CD3 (1 mg/ml), CD8 (5 mg/ml), and
CD11a (5 mg/ml) and containing culture
medium with IL-2. After 2 d, 5 ml medium
was removed from each culture and re-
placed with 5 ml medium containing IL-2,
IL-2 1 IL-4, or IL-2 1 IL-4 1 anti–IFN-g
mAb as indicated above the panels. Cloning
efficiencies at day 6 were 16% (mean clone
size 30 6 39, n = 48), 15% (49 6 50, n = 44),
and 14% (52 6 55, n = 41), respectively.
The figure shows the results of RT-PCR
analysis of all clones of $20 cells that
yielded a CD3e PCR product (all but one
clone). Detection of a cytokine PCR prod-
uct is indicated by shading of the boxes. The
number of cells in each clone is indicated at
the right, and the frequency of expression of
each cytokine is indicated at the bottom of
the panels.1085 Doyle et al.
from normal LNs and infected lung were cultured with an-
tireceptor mAb and IL-2. After 2 d, when significant num-
bers had undergone one or two divisions, individual
daughter or granddaughter cells were transferred into new
cultures with or without exogenous IL-4. Subclones were
analyzed for CD3e and cytokine mRNAs 4–5 d later.
Table I summarizes the mean cloning efficiencies, sub-
clone sizes, and frequencies of CD3e and cytokine mRNA
detection in subclones for all paired daughter analyses per-
formed in this way with cells from normal LNs and influ-
enza-infected lung. In general, influenza lunghigh cells sub-
cloned at lower frequency and formed smaller subclones by
day 6 than normal LNlow or influenza lunglow cells, indicat-
ing that even those influenza lunghigh cells that divided in
the first 2 d were less able to undergo extended prolifera-
tion than the other populations. Most subclones of all cell
types expressed IFN-g mRNA, whereas IL-2 was prefer-
entially expressed by normal LNlow and influenza lunglow
subclones. As observed in our previous analysis of naive
C57BL/6 CD81 LN T cells (7), some subclones of all cell
types expressed IL-4 and/or IL-10 mRNA in the absence
of exogenous IL-4, but frequencies were significantly
higher among subclones grown with IL-4. IL-4 expression
frequencies were more strongly affected by exogenous IL-4
than expression frequencies of any of the other cytokines
tested.
Fig. 3 shows the cytokine profiles of 12 families of sub-
clones generated from each subset. Three or four subclones
per family are illustrated in those cases where the original
cell had divided twice by day 2 and more than two of its
progeny yielded a CD3e1 subclone. These examples illus-
trate several features of the whole data set. First, IFN-g,
IL-4, and IL-10 could be detected in almost any combina-
tion. Second, many subclones displayed identical cytokine
profiles within a family regardless of culture conditions,
while others displayed differences in the presence and ab-
sence of added IL-4; paired subclones grown in the same
conditions also sometimes displayed different profiles.
Third, IFN-g expression was more frequently gained than
lost when subclones were grown with IL-4. Finally, in
many families where a subclone grown without IL-4 ex-
pressed IL-4 or IL-10, its sibling grown with IL-4 also pro-
duced this cytokine.
The outcome of all paired daughter analyses for IL-4 and
IL-10 expression is summarized in Table II. Many families
in all groups displayed a “2/2” phenotype for IL-4 ex-
pression, i.e., this cytokine was not expressed by subclones
grown either in the absence or in the presence of IL-4.
Several other families included subclones that expressed
IL-4 in one (1/2 and 2/1 phenotypes) or both (1/1)
types of culture. If detection of IL-4 mRNA were entirely
dependent on addition of IL-4 to the cultures, the fre-
quency of families with a 2/1 phenotype would give a di-
rect minimal estimate of the frequency of IL-4–inducible
Table I. Efficiencies of T Cell Cloning and mRNA Detection among Subclones Obtained in Paired Daughter Analyses
Parameter
Normal LNlow Influenza lunglow Influenza lunghigh
IL-2 IL-2 1 IL-4 IL-2 IL-2 1 IL-4 IL-2 IL-2 1 IL-4
Primary cultures
No. of parent cells cultured 1,260 2,040 2,622
% cultures with $2 cells at day 2* 34 (17–48) 7.8 (4.2–12) 17 (16–22)
Secondary cultures
No. of cells transferred on day 2 259 264 168 117 322 293
% cells that subcloned by day 6 81 (80–81) 74 (70–80) 79 (52–91) 72 (48–82) 45 (34–56) 46 (39–57)
Mean subclone size on day 6 131 6 60 89 6 49 82 6 61 68 6 50 40 6 49 43 6 49
No. of subclones assayed by RT-PCR 112 114 88 92 89 94
No. of CD3e1 subclones 109 108 85 91 87 92
% IFN-g1 subclones 85 86 76 92‡ 77 93‡
% IL-21 subclones 33 49‡ 8.2 11 0 1.1
% IL-41 subclones 25 73‡ 13 34‡ 6.9 20‡
% IL-101 subclones 18 51‡ 9.4 23‡ 21 36‡
No. of informative subclone families 93 71 74
Data are expressed as the weighted arithmetic mean of two experiments with normal LNlow cells, four experiments with influenza lunglow cells, and
five experiments with influenza lunghigh cells with the range of values shown in parentheses. Subclone size is shown as the arithmetic mean 6 SD.
Cytokine-positive clones are those in which both CD3e and the indicated cytokine mRNAs were detected after RT-PCR. Informative subclone
families are those in which CD3e mRNA was detected in at least one subclone grown in IL-2 and at least one grown in IL-2 1 IL-4.
*These values are influenced by the duration of primary culture (40–48 h) and do not accurately reflect proliferative potential.
‡Significantly different from the frequency detected in the absence of exogenous IL-4 (P , 0.05).1086 Flexible Cytokine Profiles of Activated CD81 T Cells from an Effector Site
multipotential parent cells. However, in this study, there
was a measurable level of IL-4 expression that occurred in-
dependently of exogenous IL-4, indicated by the frequency
of 1/2 and 1/1 families. Therefore, we estimated the
frequency of multipotential parent cells by subtracting this
IL-4–independent frequency from the sum of the 2/1
and 1/1 frequencies (Table III). Whether these calcula-
tions are based on expression of IL-4, IL-10, or both cy-
tokines, they indicate a loss of multipotentiality as CD81 T
cells differentiate from the naive state in normal LNs to the
activated state in the infected lung parenchyma.
Other analyses indicated a concomitant rise in the pro-
portion of committed cells with differentiation from the
naive to the activated state. For example, in all groups, 60%
or more of subclones grown in IL-2 alone expressed IFN-g
without IL-4. Table IV summarizes the IFN-g/IL-4 phe-
notypes of their siblings grown in IL-2 plus IL-4 and re-
veals that a markedly higher proportion displayed the same
IFN-g1 IL-42 phenotype in families derived from the most
activated lung population than in families derived from
normal LNs.
To address this issue in another way, the frequency data
in Table II were subjected to contingency table testing to
determine whether expression of IL-4 or IL-10 by sub-
clones grown with added IL-4 was statistically independent
of expression of the same cytokine by their siblings grown
without IL-4. As shown in the table, the frequencies of
each IL-4 phenotype among normal LNlow and influenza
lunglow subclone families were close to those expected by
chance, indicating that IL-4 expression was independently
regulated among subclones within these families. By the
same criterion, IL-10 expression was also independently
regulated within families of normal LNlow subclones. This
was not the case for the other sets of data. The frequen-
cies of IL-4 2/2 and 1/1 families of influenza lunghigh
cells and the frequencies of IL-10 2/2 and 1/1 families
of both influenza lunglow and influenza lunghigh cells were
significantly higher than expected by chance. This suggests
that some parents of these families were committed to the
expression or nonexpression of IL-4 and/or IL-10; their
daughter cells were therefore unaffected by exposure to
IL-4.
Discussion
Here we show that an activated, type 1–polarized, effec-
tor population of CD81 T cells isolated from the lungs of
influenza virus–infected mice is not terminally differenti-
ated. Although it includes cells that appear functionally
committed, it also contains a significant proportion of cells
able to proliferate and express IL-4 and/or IL-10 when ex-
posed to IL-4 in vitro. This indicates that some CD81 T
cells in an effector site can retain the potential to alter their
cytokine profile in response to local stimuli.
A key feature of the experimental design of this study
was the analysis of paired daughter cells, in which the abil-
ity of sister cells to give rise to subclones with different cy-
tokine profiles in different culture conditions demonstrates
the multipotentiality of their parent. This protocol has sev-
eral advantages over conventional bulk culture methods
used by several groups to assess the stability of cytokine
profiles (15, 16, 19, 36). First, it allows the fate of every
cultured cell to be monitored, so that selective growth can
be distinguished from reprogramming in response to an ex-
ogenous stimulus. Second, it enables the frequency of mul-
tipotential (programmable) cells to be estimated in hetero-
Figure 3. Cytokine mRNA expression patterns within families of sub-
clones derived from normal LNlow cells, influenza lunglow cells, and influ-
enza lunghigh cells after one or two divisions. In each group, cytokine pro-
files of 12 sequentially analyzed families from a single experiment are
shown with subclones grown in IL-2 aligned with their siblings grown in
IL-2 1 IL-4. Brackets are used to group siblings grown in the same con-
ditions. Detection of a cytokine PCR product is indicated by shading.
The number of cells in each subclone is shown at the right of the panels.1087 Doyle et al.
geneous populations. In the present study, these estimates
suggested a progressive decline in the frequency of multi-
potential cells from normal LNlow to influenza lunglow to
influenza lunghigh cells (Table III), in parallel with the ob-
served rise in their expression of cytokine genes in vivo
(Fig. 1). Third, culture of single parent cells and subcloning
of their progeny isolate these cells from the effects of cross-
regulatory cytokines from other cells, which might over-
ride the differentiative effects of IL-4 in a bulk culture (44)
and mask low frequencies of multipotential cells.
We have previously used paired daughter analysis to
evaluate the multipotentiality of CD81CD44low T cells
from the LNs of normal C57BL/6 mice and found that al-
most 90% of cells were at least bipotential for the expres-
sion of six different cytokines; based on the expression of
IL-4 alone, 50% of parent cells in that study were multipo-
tential (7). A similar figure (51%) was obtained here for
CD81CD44lowCD11alow cells from LNs of normal BALB/c
mice. Although it seems likely that most, if not all, naive
CD81 T cells are multipotential for expression of IL-4 and
other cytokines, these minimal estimates establish a baseline
for comparison with other populations. Subcloning effi-
ciencies were high for normal LN cells in the presence and
absence of IL-4, suggesting that the parent cells analyzed
were representative of the larger pool and arguing against
the selective expansion of committed cells by one or other
culture condition.
This study is, to our knowledge, the first frequency anal-
ysis of multipotentiality in T cells activated in vivo and has
yielded both expected and unexpected results. Not surpris-
ingly, the two CD81 populations isolated from 7-d influ-
enza virus–infected lung parenchyma differed markedly by
several criteria from their counterparts of naive phenotype
isolated from normal LNs. Although the influenza lunglow
population was selected for the same surface markers as the
normal LNlow cells, their frequency of IFN-g expression ex
vivo was at least three orders of magnitude higher (as as-
sessed in multiple 500-cell samples; Fig. 1). Their subclon-
ing efficiency was almost as high as the LN population, but
average subclone sizes and frequencies of IL-2, IL-4, and
IL-10 expression were lower both in the absence and pres-
ence of exogenous IL-4. The influenza lunghigh population
displayed greater differences from normal cells, including
high expression of IL-10 as well as IFN-g ex vivo, and yet
lower subcloning efficiency, subclone size, and subclone
frequencies of IL-2, IL-4, and IL-10 expression. The pro-
Table II. Decreased Responsiveness to IL-4 and Increased Commitment among Activated Cells Revealed by the Expression of IL-4 and IL-10 
within Subclone Families
Cells No.
Observed IL-4 expression (expected) Observed IL-10 expression (expected)
IL-2 IL-2 1 IL-4 IL-2 IL-2 1 IL-4
21 21
Normal LNlow 93 2 16 (15.4) 52 (52.6) 2 35 (31.4) 38 (41.6)
1 5 (5.6) 20 (19.4) 1 5 (8.6) 15 (11.4)
P 5 0.72* P 5 0.066
Influenza lunglow 71 2 38 (36.9) 23 (24.1) 2 49 (46.0) 15 (18.0)
1 5 (6.1) 5 (3.9) 1 2 (5.0) 5 (2.0)
P 5 0.46 P 5 0.007
Influenza lunghigh 74 2 56 (53.1) 13 (15.9) 2 38 (32.5) 18 (23.5)
1 1 (3.9) 4 (1.2) 1 5 (10.4) 13 (7.5)
P 5 0.002 P 5 0.003
The table shows the number of subclone families that displayed each possible combination of IL-4 or IL-10 expression by subclones grown in IL-2
alone or in IL-2 1 IL-4. Numbers in parentheses are the expected number of families with each phenotype if expression is statistically independent
in each subclone (determined from the product of the fraction of subclones grown with IL-2 that did/did not express the cytokine and the fraction
of subclones grown with IL-2 1 IL-4 that did/did not express the cytokine).
*Probability of independence of cytokine expression in related subclones determined by x2 analysis.
Table III. Estimated Frequencies of Multipotential Cells among 
CD81 T Cells Isolated from Normal LNs and Influenza
Virus–infected Lung
Cytokines
considered*
Multipotential cells (%)‡
Normal
LNlow
Influenza
lunglow
Influenza
lunghigh
IL-4 51 25 17
IL-10 35 18 17
IL-4 and/or IL-10 45 30 24
*Phenotypes of the subclone families shown in Table II were assigned
based on IL-4 expression (see Table II), IL-10 expression (Table II), or
expression of either IL-4 or IL-10 (data not shown).
‡Frequencies were estimated by the formula [f(2/1) 1 f(1/1)] 2
[f(1/2) 1 f(1/1)] where, for example, 2/1 indicates nonexpression
in IL-2 and expression in IL-2 1 IL-4.1088 Flexible Cytokine Profiles of Activated CD81 T Cells from an Effector Site
gressive loss of proliferative potential from normal LNlow to
influenza lunglow to influenza lunghigh cells, in parallel with
increased effector activity, mirrors the experience of many
investigators that effector populations are more difficult to
clone than naive populations, and probably reflects both se-
nescence and increased sensitivity to activation-induced
cell death (43, 55, 56). While the intermediate status of in-
fluenza lunglow cells implies that they are less differentiated
than influenza lunghigh cells and therefore might be their
precursors, the actual relationship between these two pop-
ulations is not known.
The loss of proliferative potential from the naive state to
the activated effector state introduces an important consid-
eration in interpreting the concomitant decline in multipo-
tential cell frequency observed here. Since the assessment
of multipotentiality depended on cloning and subcloning
parent cells, no information is available about the fraction
of influenza lung cells, especially those of CD44high
CD11ahigh phenotype, that failed to proliferate in these cul-
tures. Other experiments will be necessary to determine
whether individual activated T cells can change their cy-
tokine profile without cell division. However, since pro-
longed survival and clonal expansion are likely to improve
the chances of de novo induction of cytokine gene expres-
sion by exogenous IL-4, as recently shown for naive CD41
T cells (26, 57), we expect multipotential cells to be
found preferentially among the clonogenic cells. If this is
the case, the differences in multipotentiality between influ-
enza lunghigh cells and the other two CD81 populations an-
alyzed here would be compounded by their differences in
clonogenicity and would therefore be greater than indi-
cated by the estimates in Table III.
The detection of IL-4 and IL-10 mRNAs at higher fre-
quencies in subclones grown with IL-4 than in those
grown without IL-4 was not due to any detectable en-
hancement of subclone size. Although mean subclone sizes
varied between the three populations, they were not signif-
icantly affected within each population by exogenous IL-4
(Table I). Moreover, the minimum, median, and mean
subclone sizes of IL-41 and IL-101 subclones were gener-
ally lower among those grown with IL-4 than those grown
without IL-4 (data not shown). This suggests that IL-4 in-
creased the probability of expression of these cytokines at
the single-cell level, accelerating the onset of their expres-
sion as a clone expands (58).
In addition to demonstrating that some cells retain their
multipotentiality after activation in vivo, this study pro-
vided evidence for a concomitant increase in the propor-
tion of committed cells. Sharing of the IFN-g1 IL-42 phe-
notype by siblings grown in the absence and presence of
added IL-4 was progressively more common among fami-
lies derived from normal LNlow, influenza lunglow, and in-
fluenza lunghigh cells. Statistical analysis also suggested that
some influenza lunghigh cells were committed to IL-4 or IL-
10 expression or nonexpression. It is not possible from this
analysis to conclude whether a given family whose sub-
clones displayed the same IL-4 or IL-10 phenotype in the
absence and presence of exogenous IL-4 (2/2 or 1/1
phenotypes, as shown in Table II) was derived from a com-
mitted parent. However, x2 testing indicated that influenza
lunghigh cells gave rise to such families at a significantly
higher frequency than expected by chance. By contrast, a
similar analysis of the data for normal LNlow cells suggested
that cytokine expression was regulated independently in re-
lated subclones, as expected if most of these cells are multi-
potential. The result for influenza lunglow cells was mixed,
indicating independent regulation of IL-4 expression but
higher than expected occurrence of 2/2 and 1/1 fami-
lies for IL-10 expression.
Collectively, these data indicate substantial heterogeneity
within the most activated fraction of lung CD81 cells, both
in proliferative potential and in their flexibility to change
cytokine profile in response to exogenous IL-4. This is de-
spite the fact that the CD44highCD11ahigh fraction contains
essentially all the IFN-g–producing effector cell activity
detected in the lung CD81 fraction at this stage of influ-
enza infection (48, 49) and might be expected to comprise
terminally differentiated type 1 cells.
Influenza lunghigh cells are likely to be heterogeneous in
other ways not assessed here. Most importantly, since these
experiments have not yet been done with populations se-
lected for peptide–MHC tetramer binding, the antigen
specificity of the cells we have analyzed is not known and
may include a range of TCR affinities for several influenza
epitopes as well as irrelevant specificities. However, in ex-
periments by other groups with the A/HKx31 influenza
Table IV. Increased Stability of the IFN-g1 IL-42 Phenotype in Subclone Families Derived from Activated Cells
Cells
IL-2 IL-2 1 IL-4
IFN-g1 IL-42 IFN-g1 IL-42 IFN-g2 IL-42 IFN-g2 IL-41 IFN-g1 IL-41
Normal LNlow 56 12 0 3 41
Influenza lunglow 47 27 2 0 18
Influenza lunghigh 55 43 1 0 11
The table shows the breakdown of cytokine phenotypes among subclones grown with IL-2 1 IL-4 in those families where subclones grown in IL-2
alone displayed a IFN-g1 IL-42 phenotype. These families represent 60, 66, and 74%, respectively, of all normal LNlow, influenza lunglow, and influ-
enza lunghigh families analyzed. Data shown as number of subclone families.1089 Doyle et al.
virus strain, cells specific for the immunodominant nucleo-
protein epitope comprised 3–12% of CD81 cells in the
bronchoalveolar lavage at day 7 (59) and z20% of CD81 T
cells and 94% of CD44highCD81 T cells isolated from lung
tissue at day 8 (60). Virus-specific cells are therefore likely
to be a substantial fraction of the CD44highCD11ahighCD81
T cells isolated from lung tissue at the peak of the response
in our study. When methods become available to monitor
both antigen specificity and relative avidity in polyclonal
systems, it will be possible to determine whether multipo-
tentiality persists among the most reactive cells or is limited
to those receiving the weakest antigenic signals. In addi-
tion, isolation of antigen-specific T cells will allow multi-
potentiality to be analyzed in the small populations of cells
that persist in the lung after the peak of the primary re-
sponse and in secondary lymphoid organs as memory cells.
The proliferative history of the cells isolated from in-
fected lung is also unknown. Others have shown marked
heterogeneity in cell division number among responding
CD41 T cells in draining LNs in the first few days after im-
munization (61). We expect that both the influenza virus–
specific and other activated T cells found in the lung 7 d
after infection would also vary in their history of division
before and after recruitment to the lung. It is not yet
known whether there is any relationship between division
history and multipotentiality. Previous studies of peptide-
stimulated transgenic CD41 T cells have generally shown a
loss of flexibility at the population level by the second or
third cycle of in vitro stimulation, but proliferative re-
sponses and division numbers were not reported and these
findings cannot be readily extrapolated to the CD81 T cell
response to a replicating antigen in vivo where clonal burst
sizes are likely to be higher. However, our previous obser-
vation that multipotential cells persisted in some type 1
CD81 T cell clones through as many as 13–15 cell divi-
sions over 7 d in vitro raises the possibility that even the
most responsive, influenza virus–specific CD81 T cells ac-
tivated over the same time frame in vivo might also retain
some flexibility in their cytokine profiles.
The molecular mechanisms underlying cytokine profile
commitment in T cells are beginning to be unraveled. Loss
of responsiveness to the counter-regulatory cytokines IL-12
and IL-4 is one mechanism that perpetuates existing cyto-
kine profiles (21–24), but it is not yet known whether the
reported changes in IL-12 receptor expression and IL-4 re-
ceptor function are causally or temporally associated with
commitment. Similarly, while certain signal transducers
and transcriptional activators selectively activate or antago-
nize type 1 or type 2 cytokine expression (29–32), their re-
lationship to the loss of multipotentiality is not clear.
Changes in CpG methylation and chromatin conformation
of cytokine and other regulatory gene promoters are likely
to be important events in enabling transcription (25, 27,
28). Recent work showing that demethylation of the IFN-g
promoter after primary activation of CD81 T cells can be
faithfully inherited through at least 16 cell divisions (27)
suggests demethylation as a stable marker of gene activa-
tion. Again, however, its relationship to commitment is
unknown. Key issues are whether this or any other candi-
date commitment event is irreversible and whether it can
be permanently prevented from activating a silent cytokine
gene.
In conclusion, we have found that the activated effector
CD81 T cell population in the lungs of influenza virus–
infected mice contains both committed and multipotential
cells. The presence of multipotential cells indicates that cy-
tokine profiles are not irreversibly programmed during
priming in the draining LN. Until now, it has been unclear
whether differences in T cell cytokine profiles sometimes
noted between tissue sites during an immune response
were entirely due to preferential migration of differentiated
effector cells (48, 62–64). Our finding that some activated
T cells can proliferate and express new cytokine genes in
response to exogenous signals after recruitment to an effec-
tor site allows the possibility of substantial reshaping of the
T cell response by the local environment. It remains to be
seen whether this flexibility can be exploited to alleviate
pathological cytokine responses.
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